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INTRODUCTION 
Peptides present in the nervous system can act as  hormones, transmitters, or 
modulators of various physiological functions. It is well established that more 
than one peptide messenger can exist in a single neuron and that neuropeptides 
can often be grouped into a family based on structure similarity.' Although immu- 
nochemistry is a valuable technique in visualizing molecules present in a neuron, 
it is important to take into consideration the presence of structurally related 
peptides when designing antigens and interpreting imrnunocytochemical data. An- 
tisera that distinguish between structurally related peptides are important experi- 
mental tools to  determine expression and suggest function, as well a s  to analyze 
mutants and elucidate polypeptide precursor processing. 
One family of neuropeptides is structurally related to  the molluscan cardioex- 
citatory peptide FMRFamide' via the C-terminus -XRFamide, where X = L or  
M.3.4 Drosophila myosuppressin (TDVDHVFLRFamide; DMS) and sulfakinin 
(FDDYGHMRFamide;' DSK) have structure similarity to FMRFamide.'.' To 
study DMS and DSK expression, we have generated and characterized DMS- and 
DSK-specific antisera and performed double-label immunocytochemistry. Our 
results indicate that DMS and DSK are expressed in different neurons in the adult 
central nervous system. 
MATERIALS AND METHODS 
The antigens, TDVDHV-MAP and FDDYGH-MAP, where MAP represents 
multiple antigenic ~ e p t i d e , ~  were designed to  the variant N-terminal sequences of 
DMS and DSK, respectively. Antisera were raised in New Zealand white rabbits 
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and analyzed by indirect immunofluorescent analysis of whole-mount third-instar 
larval central nervous system tissue as previously described.* Antisera were puri- 
fied on peptide affinity columns made by coupling the antigen to Affi-gel 10 (Bio- 
Rad Labs) according to the manufacturer's specifications.* Affinity-purified anti- 
sera were characterized by preincubation with FDDYGHMRFamide or TDVDHV- 
FLRFamide prior to  immunocytochemistry. 
Double-label immunochemistry was performed using a modified single-label 
method.X Whole-mount tissue preparations were incubated with the first primary 
antisera for 4-6 h. rinsed in 0.5 M sodium phosphate, pH 7.2.  with 0.2% Triton 
X-100 and I %  sodium azide (PTN).  incubated in C Y k o n j u g a t e d  Fab fragment 
goat anti-rabbit secondary antibody (Jackson ImmunoResearch Labs, West Grove, 
PA) for 4-6 h, rinsed in PTN for 2 h .  incubated in the second primary antisera 
for 4-6 h ,  rinsed in PTN for 2 h. and incubated in FII'C-conjugated goat anti- 
rabbit secondary antibody (Sigma. St. Louis. MO) for 4-6 h. Tissue was then 
extensively washed and prepared for microscopy as  previously described.* Data, 
collected with a Bio-Rad MRC600 laser scanning confocal microscope equipped 
with a Kr-Ar laser attached to a Nikon inverted microscope. were processed with 
Adobe Photoshop and transferred to Kodak slide film using a Macintosh Quadra 
800 and Lasergraphics LFR-X. 
RESULTS AND DISCUSSION 
Nomenclature used in describing the neuronal staining of DMS and DSK 
antisera is based on previous publications identifying FMRFamide-like immunore- 
active materials.5~h.y-" immunoreactivity was observed bilaterally symmetric to 
the midline such that reference to one neuron indicates that there were two neurons 
positioned bilaterally symmetric to one another. Signal intensity was strong and 
consistent. and no fewer than eight preparations were analyzed. 
Antisera to FMRFamide have been used to  stain Dro.sophilrr neural tissue;?-!' 
however. given the number of FMRFamide-like peptides and that antisera to  
FMRFamide recognize the common C-terminal structure, the data are ambiguous 
and the expression patterns of individual FMRFamide-like peptides cannot be 
identified. To study the expression of peptides structurally related to FMRFamide, 
we generated antisera to multiple antigenic peptide5 designed to  the variant N- 
terminal sequences. We chose to use MAP antigens because of the advantages 
that they offer including the fact that no carrier molecule is required and that 
multiple copies of the antigen are present in a single molecule.' 
To study whether FMRFamide-like peptides coexist we established a double- 
label immunofltiorescence protocol using antisera raised in different animals of 
the same species host animal. Generation of antisera in the same species can be 
advantageous in terms of technical aspects such as  animal housing and blood col- 
lection. 
We have reported the individual expression patterns of both DMS and DSK 
immunoreactive materials during development uhing single-label immunocyto- 
chemistry.x." The neurons stained by each antisera were identificd based on 
position, comparing the staining patterns with those of FMRFamide antisera."' 
Although the single-label immunochemical data are informative. they cannot un- 
equivocally answer the question of whether these peptides are expressed in the 
same neuron or in  neurons in close proximity; i t  would be more definitive to 
compare DMS and DSK staining patterns within the same preparation. 
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FIGURE 1. Double-label imrnunofluorescence of DMS and DSK in an adult central nervous 
system. DMS antisera are recognized by FITC-labeled (green)  secondary antibody, whereas 
DSK antisera are recognized by CY3-labeled (red) secondary antibody. No neuron is stained 
by both antisera ( y ~ l l o w ) ;  some fibers appear yellow because the method of data collection 
results in overlaying neuronal projections that exist at different focal planes throughout 
the tissue. 
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We have previously presented double-label immunofluorescence data describ- 
ing the expression patterns of DMS and DSK in larval neural tissue." In this 
paper we describe a more versatiie double-label immunofluorescence protocol 
than used to study expression in larva and determine the DMS and DSK staining 
patterns in adult neural tissue. Although DMS- and DSK-specific antisera stain 
several neurons in the adult Drosophiln central nervous system (FIG. I ) ,  the 
expression patterns in the adult central nervous system are unique and nonoverlap- 
ping. Numerous neurons in close proximity to  one another are stained by either 
DMS- or DSK-specific antisera, for example, DMS-specific antisera stain a MP2 
neuron, whereas DSK-specific antisera stain two MPI neurons: however, no 
neuron is stained by both antisera, indicating that these structurally related neuro- 
peptides d o  not coexist. The nonoverlapping expression patterns for DMS and 
DSK suggest that these peptides have different roles in the central nervous system. 
SUMMARY 
Drosophiln myosuppressin (TDVDHVFLRFamide; DMS) and sulfakinin (FD- 
DYGHMRFamide: DSK) have similar C-terminal structures. To determine the 
neuronal expression patterns of these structurally related peptides, we have gener- 
ated DMS- and DSK-specific antisera to multiple antigenic peptides and performed 
double-label immunochemistry with antisera raised in different animals of the 
same species host animal. Our data indicate that DMS and DSK staining patterns 
in the adult central nervous system are unique and nonoverlapping. 
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